News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter

ESA Biosciences Corona(TM) CAD Wins 2005 R&D 100 Award

10/19/2005 5:09:25 PM

CHELMSFORD, Mass., July 5 /PRNewswire/ -- ESA Biosciences, a Magellan Biosciences company and leading provider of advanced instruments, point-of-care products, and services for biomedical research and clinical diagnostics worldwide, announced today that R&D Magazine has selected the Corona CAD (Charged Aerosol Detector) for its prestigious 2005 R&D 100 Award. The Corona is a breakthrough, universal detector technology for HPLC (High Performance Liquid Chromatography).

Dubbed "the Oscars of Invention" by The Chicago Tribune, the winning of an R&D 100 Award "provides a mark of excellence known to industry, government, and academia as proof that the product is one of the most innovative ideas of the year," according to Tim Studt, editor-in-chief of R&D Magazine. This is the second time since its introduction in October 2004 that the Corona has received high honors. This past March, the Corona won the 2005 Silver Pittcon Editors' Award for best new product.

"We are thrilled to become a member of this elite group of R&D 100 award winners, which includes products as diverse as the automated teller machine (1973) and the antismoking patch (1992)," said ESA President Walter DiGiusto, "I would like to thank all those who worked on this important product -- and that includes our customers who provided valuable input throughout its development, first outlining what their ideal instrument would comprise, and then testing to ensure that the Corona met their rigorous demand."

According to ESA Vice President of Sales and Marketing John Christensen, recognizing the significant limitations of currently available technology, the company set out to develop the first truly universal detector for HPLC capable of performing the kind of rigorous, repeatable qualitative and quantitative analyses that pharmaceutical and other-industry customers require. "In pharmaceutical applications -- where identification of contaminants, or a precise understanding of how and why a compound degrades, or an exact quantitation of active and inactive ingredients can literally be a matter of life and death -- manufacturers have had to rely on imprecise tools that can only illuminate part of the equation. Our customers were looking for more-complete answers so they could leave the guesswork out of their critical decisions affecting the public's health and well-being and their companies' reputation and bottom line."

The Corona CAD is a breakthrough device because it is the only available technology to simultaneously offer the following benefits in one, rugged, cost-effective, easy-to-use instrument:

* Excellent sensitivity * Wide dynamic range * Superior reproducibility * More consistent response * Broad applicability * Intuitive operation About ESA Biosciences

Founded in 1968, ESA Biosciences, Inc. is a leading manufacturer and supplier of analytical instruments for the life science, clinical diagnostic, drug discovery, and pharmaceutical industries. The company offers a complete line of HPLC systems, components, and advanced detectors, along with a broad range of analytical services. For more information, visit ESA's Web site at .

About Magellan Biosciences

Magellan Biosciences develops advanced instruments, automated systems, point-of-care products, and consumables for biomedical research and clinical diagnostics worldwide. These tools enable scientists and clinicians to produce better, more-reliable results. And improved results help drive better outcomes -- a new understanding of health and disease, earlier, more-accurate diagnoses -- breakthrough discoveries that can lead to novel treatments, new cures -- innovations to enhance life. For more information, visit .

Magellan Biosciences

CONTACT: Caroline A. Grossman of Magellan Biosciences, +1-781-771-5579,

Read at

comments powered by Disqus